aTyr Pharma

(NASDAQ) ATYR

Current Price$0.81

Market Cap$75.01M

Since IPO (2015)-100%

5 Year-80%

1 Year-77%

1 Month+4%

aTyr Pharma Financials at a Glance

Market Cap

$75.01M

Revenue (TTM)

$190.00K

Net Income (TTM)

$74.12M

EPS (TTM)

$-0.80

P/E Ratio

-0.96

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Price

$0.81

Volume

4,992

Open

$0.78

Price

$0.81

Volume

4,992

Open

$0.78

Previous Close

$0.81

Daily Range

$0.78 - $0.81

52-Week Range

$0.64 - $7.29

Dividend

$0.00

Beta (Volatility)

0.80 (Low)

Price

$0.81

Volume

4,992

Open

$0.78

Previous Close

$0.81

Daily Range

$0.78 - $0.81

52-Week Range

$0.64 - $7.29

ATYR News

research scientists drugs pharma biotech

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About aTyr Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Sanjay S. Shukla, MD

Website

www.atyrpharma.com

Headquarters

San Diego, CA 92121, US

ATYR Financials

Key Financial Metrics (TTM)

Gross Margin

-118%

Operating Margin

-409%

Net Income Margin

-390%

Return on Equity

-108%

Return on Capital

-98%

Return on Assets

-79%

Earnings Yield

-1.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$75.01M

Shares Outstanding

98.05M

Volume

4.99K

Avg. Volume

1.36M

Financials (TTM)

Gross Profit

$1.36M

Operating Income

$77.63M

EBITDA

$76.07M

Operating Cash Flow

$61.99M

Capital Expenditure

$77.00K

Free Cash Flow

$62.06M

Cash & ST Invst.

$78.69M

Total Debt

$12.03M

aTyr Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$394.00K

+96.8%

Gross Margin

0.00%

N/A

Market Cap

$75.01M

N/A

Market Cap/Employee

$1.34M

N/A

Employees

N/A

Net Income

$13.96M

+6.7%

EBITDA

$14.40M

+7.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$66.65M

+13.3%

Accounts Receivable

$873.00K

-49.7%

Inventory

$0.00

N/A

Long Term Debt

$10.57M

-12.2%

Short Term Debt

$1.47M

+17.1%

Return on Assets

-78.71%

N/A

Return on Invested Capital

-98.24%

N/A

Free Cash Flow

$12.23M

+7.1%

Operating Cash Flow

$12.20M

+7.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CAMPCAMP4 Therapeutics Corporation

CAMPCAMP4 Therapeutics Corporation$4.17+3.99%

ACRVAcrivon Therapeutics, Inc. Common Stock

ACRVAcrivon Therapeutics, Inc. Common Stock$1.85+2.21%

DTILPrecision BioSciences, Inc.

DTILPrecision BioSciences, Inc.$7.15+3.62%

ALXOALX Oncology Holdings Inc.

ALXOALX Oncology Holdings Inc.$1.70+7.59%

HYFTMindWalk Holdings Corp.

HYFTMindWalk Holdings Corp.$1.19+0.00%

MGXMetagenomi, Inc. Common Stock

MGXMetagenomi, Inc. Common Stock$1.38+2.22%

QNCXQuince Therapeutics, Inc.

QNCXQuince Therapeutics, Inc.$1.31+6.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.48-0.00%

NOKNokia

NOKNokia$12.91+0.04%

SOFISoFi Technologies

SOFISoFi Technologies$16.10+0.04%

AAPLApple

AAPLApple$271.35+0.00%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.63+0.10%

MARAMara Holdings

MARAMara Holdings$11.99+0.12%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.54+0.03%

Questions About ATYR

What is the current price of aTyr Pharma?

aTyr Pharma is trading at $0.81 per share.

What is the 52-week range for aTyr Pharma?

Over the past 52 weeks, aTyr Pharma has traded between $0.64 and $7.29.

How much debt does aTyr Pharma have?

As of the most recent reporting period, aTyr Pharma reported total debt of $12.03M.

How much cash does aTyr Pharma have on hand?

aTyr Pharma reported $10.74M in cash and cash equivalents in its most recent financial results.

What is aTyr Pharma’s dividend yield?

aTyr Pharma does not currently have a dividend yield.

aTyr Pharma

aTyr Pharma Financials at a Glance

ATYR News

1 Small-Cap Biotech Stock Poised for a Breakout

2 Small-Cap Biotech Stocks Well Positioned for a Breakout

1 Small-Cap Biotech Stock Poised for a Breakout

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About aTyr Pharma

ATYR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

aTyr Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ATYR

What is the current price of aTyr Pharma?

What is the 52-week range for aTyr Pharma?

How much debt does aTyr Pharma have?

How much cash does aTyr Pharma have on hand?

What is aTyr Pharma’s dividend yield?

Premium Investing Services